AB Science reports completion of the step 3 of phase 1, evaluating the combination of AB8939 with venetoclax for the treatment of refractory or relapsed AML
'An extreme end of human genetic variation': Ancient humans were isolated in southern Africa for nearly 100,000 years, and their genetics are stunningly different